Literature DB >> 19755575

An FMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD.

Bradley S Peterson1, Marc N Potenza, Zhishun Wang, Hongtu Zhu, Andrés Martin, Rachel Marsh, Kerstin J Plessen, Shan Yu.   

Abstract

OBJECTIVE: The authors examined the effect of psychostimulants on brain activity in children and adolescents with ADHD performing the Stroop Color and Word Test.
METHOD: The authors acquired 52 functional MRI scans in 16 youths with ADHD who were known responders to stimulant medication and 20 healthy comparison youths. Participants with ADHD were scanned on and off medication in a counterbalanced design, and comparison subjects were scanned once without medication.
RESULTS: Stimulant medication significantly improved suppression of default-mode activity in the ventral anterior cingulate cortex in the ADHD group. When off medication, youths with ADHD were unable to suppress default-mode activity to the same degree as comparison subjects, whereas when on medication, they suppressed this activity to comparison group levels. Greater activation of the lateral prefrontal cortex when off medication predicted a greater reduction in ADHD symptoms when on medication. Granger causality analyses demonstrated that activity in the lateral prefrontal and ventral anterior cingulate cortices mutually influenced one another but that the influence of the ventral anterior cingulate cortex on the lateral prefrontal cortex was significantly reduced in youths with ADHD off medication relative to comparison subjects and increased significantly to normal levels when ADHD youths were on medication.
CONCLUSIONS: Psychostimulants in youths with ADHD improved suppression of default-mode activity in the ventral anterior cingulate and posterior cingulate cortices, components of a circuit in which activity has been shown to correlate with the degree of mind-wandering during attentional tasks. Stimulants seem to improve symptoms in youths with ADHD by normalizing activity within this circuit and improving its functional interactions with the lateral prefrontal cortex.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19755575      PMCID: PMC3289412          DOI: 10.1176/appi.ajp.2009.08050724

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  41 in total

1.  Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function.

Authors:  D A Gusnard; E Akbudak; G L Shulman; M E Raichle
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

2.  Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control.

Authors:  A W MacDonald; J D Cohen; V A Stenger; C S Carter
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

3.  Emotion-induced changes in human medial prefrontal cortex: I. During cognitive task performance.

Authors:  J R Simpson; A Z Snyder; D A Gusnard; M E Raichle
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

4.  Psychological assessment of children with minimal brain dysfunction.

Authors:  C K Conners
Journal:  Ann N Y Acad Sci       Date:  1973-02-28       Impact factor: 5.691

5.  Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network.

Authors:  S Overmeyer; E T Bullmore; J Suckling; A Simmons; S C Williams; P J Santosh; E Taylor
Journal:  Psychol Med       Date:  2001-11       Impact factor: 7.723

6.  The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder.

Authors:  Keith M Shafritz; Karen E Marchione; John C Gore; Sally E Shaywitz; Bennett A Shaywitz
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

7.  Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder.

Authors:  Adam R Aron; Jonathon H Dowson; Barbara J Sahakian; Trevor W Robbins
Journal:  Biol Psychiatry       Date:  2003-12-15       Impact factor: 13.382

8.  Effect of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder: normalization of behavior but not related brain activity.

Authors:  Julie B Schweitzer; Douglas O Lee; Russell B Hanford; Caroline F Zink; Timothy D Ely; Malle A Tagamets; John M Hoffman; Scott T Grafton; Clinton D Kilts
Journal:  Biol Psychiatry       Date:  2004-10-15       Impact factor: 13.382

9.  Differential patterns of striatal activation in young children with and without ADHD.

Authors:  Sarah Durston; Nim T Tottenham; Kathleen M Thomas; Matthew C Davidson; Inge-Marie Eigsti; Yihong Yang; Aziz M Ulug; B J Casey
Journal:  Biol Psychiatry       Date:  2003-05-15       Impact factor: 13.382

10.  Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder.

Authors:  Elizabeth R Sowell; Paul M Thompson; Suzanne E Welcome; Amy L Henkenius; Arthur W Toga; Bradley S Peterson
Journal:  Lancet       Date:  2003-11-22       Impact factor: 79.321

View more
  104 in total

Review 1.  Large-scale brain systems in ADHD: beyond the prefrontal-striatal model.

Authors:  F Xavier Castellanos; Erika Proal
Journal:  Trends Cogn Sci       Date:  2011-12-12       Impact factor: 20.229

2.  Effect of dopamine transporter genotype on intrinsic functional connectivity depends on cognitive state.

Authors:  Evan M Gordon; Melanie Stollstorff; Joseph M Devaney; Stephanie Bean; Chandan J Vaidya
Journal:  Cereb Cortex       Date:  2011-11-02       Impact factor: 5.357

3.  Neural correlates of cognitive flexibility in children at risk for bipolar disorder.

Authors:  Pilyoung Kim; Sarah E Jenkins; Megan E Connolly; Christen M Deveney; Stephen J Fromm; Melissa A Brotman; Eric E Nelson; Daniel S Pine; Ellen Leibenluft
Journal:  J Psychiatr Res       Date:  2011-10-22       Impact factor: 4.791

4.  Working memory network alterations and associated symptoms in adults with ADHD and Bipolar Disorder.

Authors:  Ariel Brown; Joseph Biederman; Eve Valera; Alexandra Lomedico; Megan Aleardi; Nikos Makris; Larry J Seidman
Journal:  J Psychiatr Res       Date:  2012-01-23       Impact factor: 4.791

Review 5.  Utility of functional MRI in pediatric neurology.

Authors:  Emily R Freilich; William D Gaillard
Journal:  Curr Neurol Neurosci Rep       Date:  2010-01       Impact factor: 5.081

6.  Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate.

Authors:  Elizabeth B Liddle; Chris Hollis; Martin J Batty; Madeleine J Groom; John J Totman; Mario Liotti; Gaia Scerif; Peter F Liddle
Journal:  J Child Psychol Psychiatry       Date:  2010-11-12       Impact factor: 8.982

7.  Urinary tetrahydrocannabinol is associated with poorer working memory performance and alterations in associated brain activity.

Authors:  Max M Owens; Shannon McNally; Tashia Petker; Michael T Amlung; Iris M Balodis; Lawrence H Sweet; James MacKillop
Journal:  Neuropsychopharmacology       Date:  2018-10-10       Impact factor: 7.853

Review 8.  Annual research review: Current limitations and future directions in MRI studies of child- and adult-onset developmental psychopathologies.

Authors:  Guillermo Horga; Tejal Kaur; Bradley S Peterson
Journal:  J Child Psychol Psychiatry       Date:  2014-01-20       Impact factor: 8.982

9.  Estimating the passage of minutes: deviant oscillatory frontal activity in medicated and unmedicated ADHD.

Authors:  Tony W Wilson; Elizabeth Heinrichs-Graham; Matthew L White; Nichole L Knott; Martin W Wetzel
Journal:  Neuropsychology       Date:  2013-09-16       Impact factor: 3.295

10.  Functional MRI evidence for fine motor praxis dysfunction in children with persistent speech disorders.

Authors:  Erin Redle; Jennifer Vannest; Thomas Maloney; Rebecca K Tsevat; Sarah Eikenberry; Barbara Lewis; Lawrence D Shriberg; Jean Tkach; Scott K Holland
Journal:  Brain Res       Date:  2014-12-04       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.